Join us at medtech 10 — where the focus will be on bringing together the most innovative thinkers in the industry to exchange ideas, insights and reflections.

More than 300 medtech professionals, students and suppliers will share their thoughts about the state of the industry and ways to move it forward. Interactive panels, breakout sessions and hands-on workshops encourage spirited discussions and the evolution of new ideas. Come share your insights and help us put North Carolina medtech on the map.


Tuesday, November 30

8:30 - 10:45 am
Branding Workshop: The Identity Project

The Identity Project workshop will teach you about the connections
between a powerful compelling identity and the success of your company
and products.The workshop will feature:

  • Premier screening of the Identity Project documentary - follow one medtech company, Oncoscope’s, journey through the branding process
  • Q & A panel with Oncoscope, including President & CEO, Perry Genova
  • Interactive group branding exercises to help uncover truths about your brand
Grant Writing Workshop:

Federal R&D Funding for Small MedTech firms: An Introduction to Competing in theSBIR and STTR Programs

9:30 - 11:00 am
Welcome Reception and Registration

11:00 - 11:10 am
Opening Remarks

11:10 - 12:15 pm
Dollars & Deals: The State of the Medtech Industry

How is the medical device industry doing during this challenging environment of economic recovery, changing regulations and political volatility? A study of the medtech industry by Ernst & Young will be presented followed by a panel discussion of veteran medtech industry experts. Views of industry, investors, and bankers will be shared on both the regional and national outlook.

  • Henry Tung, MD, MBA, Senior VP of Strategy and Business Development, Smith and Nephew
  • R. Scott Barry, Partner, Essex Woodlands Health Ventures
  • Michael Constantino, MD, Partner, Health Sciences, Ernst & Young
  • Milton Hsu, MD, VP Investment Banking, Barclays Capital
  • James Rosen, Partner, Intersouth Partners
12:30 - 1:15 pm
Sector Breakouts

Diabetes

  • John Buse, MD, PhD, Professor-Medicine, Diabetes Care Center, Chief-Division of Endocrinology, Executive Associate Dean-Clinical Research, UNC at Chapel Hill
  • Walt Gall, Program Manager-Diagnostic Development, Metabolon
  • Andrew Young, MD PhD, VP and Head Enteroendocrine Biology, GlaxoSmithKline
Oncology: Challenges, Needs & Adoption

Although many forms of cancer are on the decline, it remains a leading cause of death in western society. This panel will explore the role of medical technology in diagnosing and treating cancer, will examine the major drivers shaping medical technology development in this space, and discuss the criteria necessary for successful adoption.

  • Douglas Malinowski, PhD, VP and CSO, BD Diagnostics
  • Nicholas Shaheen, MD, MPH Director, Center for Esophageal Diseases and Swallowing, UNC School and Medicine
  • Myla Lai-Goldman, MD, CEO and CSO, CancerGuide Diagnostics
Orthopedics: Biologics and Acquisitions

Orthobiologics is not only the fastest growing segment of the $33 billion global orthopedics market, it's the center producing breakthrough products rather than incremental innovation. This panel will only illuminate the growth opportunities in allograft tissue, synthetic bone grafts, proteins, stem cells, and ultrasound therapies, it will examine the importance of surgeon relationships and the deal criteria that influences the probability and success of acquisitions of emerging therapies.

  • Peyton Anderson, CEO, Affinergy
  • Ted Davis, Senior VP - Corporate Development, Wright Medical Technology
  • Henry Tung, MD, MBA, Senior VP of Strategy and Business Development, Smith & Nephew
1:30 - 2:30 pm
Luncheon: Riding the IPO Wave – before, during and after; past, present and future

An IPO used as an "exit" event for earlystage investors. Now, if you can get it, it is another tool in the funding toolbox for medtech companies. Rick will share with us his experiences with three IPOs in the past eighteen years, and provide insights on how to use an IPO and other funding mechanisms to capitalize medtech companies.

Rick Randall, CEO, Trans1

2:45 - 3:45 pm
Think Tank Workshop: Igniting Innovation

3:45 - 4:15 pm
Innovation Corridor

4:15 - 5:00 pm
FDA Town Hall Meeting

  • Video Q&A with the FDA's Jeff Shuren
  • Tim Willis, TearScience
  • Tammy Carrera, VP Quality & Regulatory Affairs, Transenterix
  • SK McGarvey
  • Phil Phillips, President, Phillips Consulting Group
5:00 - 5:15 pm
Closing Remarks

5:15 pm
Medtech Celebration